# Evaluation of Baroreflex Activation Therapy in Patients With Advanced Heart Failure

> **NCT03230643** · — · COMPLETED · sponsor: **Heart and Diabetes Center North-Rhine Westfalia** · enrollment: 40 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Barostim neo implantation

## Key facts

- **NCT ID:** NCT03230643
- **Lead sponsor:** Heart and Diabetes Center North-Rhine Westfalia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2019-10-15
- **Final completion:** 2020-05-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03230643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03230643, "Evaluation of Baroreflex Activation Therapy in Patients With Advanced Heart Failure". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03230643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*